Novel Substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones As Potent Radio-sensitizing Agents

Overview

Journal Bioorg Med Chem Lett

Specialty Biochemistry

Date 2009 Dec 17

PMID 20005706

Citations 15

Authors

Y Thirupathi Reddy

Konjeti R Sekhar

Nidhish Sasi

P Narsimha Reddy

Michael L Freeman

Peter A Crooks

Affiliations

Soon will be listed here.

Abstract

A series of (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-dione (9a-9m) and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-trione (10a-10i) derivatives that incorporate a variety of aromatic substituents in both the indole and N-benzyl moieties have been synthesized. These analogs were evaluated for their radiosensitization activity against the HT-29 cell line. Three analogs, 10a, 10b, and 10c were identified as the most potent radiosensitizing agents.

Citing Articles

Targeting NPM1 in irradiated cells inhibits NPM1 binding to RAD51, RAD51 foci formation and radiosensitizes NSCLC.

Traver G, Sekhar K, Crooks P, Keeney D, Freeman M Cancer Lett. 2020; 500:220-227.

PMID: 33358698 PMC: 7822076. DOI: 10.1016/j.canlet.2020.12.023.

Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs.

Shankar B, Jalapathi P, Saikrishna B, Perugu S, Manga V Chem Cent J. 2018; 12(1):1.

PMID: 29318401 PMC: 5760494. DOI: 10.1186/s13065-017-0364-3.

In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis.

Yeo S, Jin C, Kim S, Park H Korean J Parasitol. 2016; 54(2):155-61.

PMID: 27180573 PMC: 4870977. DOI: 10.3347/kjp.2016.54.2.155.

Molecules that target nucleophosmin for cancer treatment: an update.

Di Matteo A, Franceschini M, Chiarella S, Rocchio S, Travaglini-Allocatelli C, Federici L Oncotarget. 2016; 7(28):44821-44840.

PMID: 27058426 PMC: 5190137. DOI: 10.18632/oncotarget.8599.

1-Benzyl-2-methyl-3-indolylmethylene barbituric acid derivatives: Anti-cancer agents that target nucleophosmin 1 (NPM1).

Penthala N, Ketkar A, Sekhar K, Freeman M, Eoff R, Balusu R Bioorg Med Chem. 2015; 23(22):7226-33.

PMID: 26602084 PMC: 4747820. DOI: 10.1016/j.bmc.2015.10.019.

References

Dewey W, Westra A, Miller H, Nagasawa H . Heat-induced lethality and chromosomal damage in synchronized Chinese hamster cells treated with 5-bromodeoxyuridine. Int J Radiat Biol Relat Stud Phys Chem Med. 1971; 20(6):505-20. DOI: 10.1080/09553007114551421. View

Sekhar K, Sonar V, Muthusamy V, Sasi S, Laszlo A, Sawani J . Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway. Cancer Res. 2007; 67(2):695-701. DOI: 10.1158/0008-5472.CAN-06-3212. View

Lepock J, Frey H, Rodahl A, Kruuv J . Thermal analysis of CHL V79 cells using differential scanning calorimetry: implications for hyperthermic cell killing and the heat shock response. J Cell Physiol. 1988; 137(1):14-24. DOI: 10.1002/jcp.1041370103. View

Kampinga H, Dikomey E . Hyperthermic radiosensitization: mode of action and clinical relevance. Int J Radiat Biol. 2001; 77(4):399-408. DOI: 10.1080/09553000010024687. View

Nielsen O, Horsman M, Overgaard J . A future for hyperthermia in cancer treatment?. Eur J Cancer. 2001; 37(13):1587-9. DOI: 10.1016/s0959-8049(01)00193-9. View

Glofcheski D, Kruuv J, Lepock J . Relationship between hyperthermic cell killing and protein denaturation by alcohols. Radiat Res. 1981; 87(2):284-99. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

Haasbeek C, Uitterhoeve A, van der Velden J, Gonzalez D, Stalpers L . Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery. Radiother Oncol. 2008; 89(2):197-204. DOI: 10.1016/j.radonc.2008.01.004. View

Sonar V, Thirupathi Reddy Y, Sekhar K, Sasi S, Freeman M, Crooks P . Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Bioorg Med Chem Lett. 2007; 17(24):6821-4. PMC: 3726020. DOI: 10.1016/j.bmcl.2007.10.035. View

10.

Horsman M, Overgaard J . Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol). 2007; 19(6):418-26. DOI: 10.1016/j.clon.2007.03.015. View

11.

Dalerba P, Dylla S, Park I, Liu R, Wang X, Cho R . Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A. 2007; 104(24):10158-63. PMC: 1891215. DOI: 10.1073/pnas.0703478104. View

12.

Fredriksson I, Liljegren G, Arnesson L, Emdin S, Palm-Sjovall M, Fornander T . Local recurrence in the breast after conservative surgery--a study of prognosis and prognostic factors in 391 women. Eur J Cancer. 2002; 38(14):1860-70. DOI: 10.1016/s0959-8049(02)00219-8. View

13.

Iliakis G, Seaner R, Okayasu R . Effects of hyperthermia on the repair of radiation-induced DNA single- and double-strand breaks in DNA double-strand break repair-deficient and repair-proficient cell lines. Int J Hyperthermia. 1990; 6(4):813-33. DOI: 10.3109/02656739009140828. View

14.

Nguyen V, Morange M, Bensaude O . Protein denaturation during heat shock and related stress. Escherichia coli beta-galactosidase and Photinus pyralis luciferase inactivation in mouse cells. J Biol Chem. 1989; 264(18):10487-92. View

15.

Thacker J . The study of responses to 'model' DNA breaks induced by restriction endonucleases in cells and cell-free systems: achievements and difficulties. Int J Radiat Biol. 1994; 66(5):591-6. DOI: 10.1080/09553009414551671. View

16.

Gao X, Saha D, Kapur P, Anthony T, Livingston E, Huerta S . Radiosensitization of HT-29 cells and xenografts by the nitric oxide donor DETANONOate. J Surg Oncol. 2009; 100(2):149-58. DOI: 10.1002/jso.21318. View

17.

Lepock J . How do cells respond to their thermal environment?. Int J Hyperthermia. 2005; 21(8):681-7. DOI: 10.1080/02656730500307298. View

18.

Rodel C, Sauer R . Radiotherapy and concurrent radiochemotherapy for rectal cancer. Surg Oncol. 2004; 13(2-3):93-101. DOI: 10.1016/j.suronc.2004.08.012. View